Insect resistance management in GM crops: Past, present and future
Article Abstract:
Transgenic plants expressing insecticidal proteins from the bacterium Baccilus thuringiensis (Bt) were commercialized in 1996 amid concern from some experts that the widespread use of Bt crops would inevitably lead to resistance and the loss of 'public good'. Researchers and regulators are again looking for opportunities to reassess the risk of resistance and the most effective strategies to preserve Bt and other novel inset-resistant crops in development.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Transgenic plants expressing two Bacillus thuringiensis toxins delay insect resistance evolution
Article Abstract:
A unique model system consisting of Bt transgenic broccoli plants and the diamondback moth, Plutella xylostella is developed. It is reported that plants containing two dissimilar Bt toxin genes can delay resistance more effectively than single-toxin plants used sequentially.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Assessment of risk of insect-resistance transgenic crops to nontarget arthropods
Article Abstract:
The basic principle and rationale of the scientifically rigorous tiered approach to assess the possible risks to nontarget arthropods (NTAs) posed by insect-resistant, genetically modified (IRGM) crops, within regulatory toxicology and environmental sciences is analyzed.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Total quality management as competitive advantage: a review and empirical study. Organizational alignment as competitive advantage
- Abstracts: The state income tax treatment of selling a joint venture interest. Drafting partnership allocations
- Abstracts: Mending the message. Alternative splicing in disease and therapy. Spliceosome-mediated RNA trans-splicing as a tool for gene therapy
- Abstracts: Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Approaches for the sequence-specific knockdown of mRNA
- Abstracts: Engineering and characterization of a superfolder green fluorescent protein. Fluorobodies combine GFP fluorescence with the binding characteristics of antibodies